Login
$HPAI
$0.28 +$0.01 (4.74%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2025
As of Jun 30, 2025
Q4 FY2024
As of Jun 30, 2024
Cash
Accounts receivable
Deferred offering costs
Amount due from a related party
Prepaid expenses and other receivables
Total current assets
Long-term investment
Intangible assets, net
Right-of-use assets, net
Total non-current assets
Total assets
Accounts payable
Income tax payable
Amount due to related parties
Convertible promissory notes
Warrant liabilities
Loans due to third parties
Accrued expenses and other liabilities
Lease liabilities
Deferred tax liabilities
Total current liabilities
Total non-current liability
Total liabilities
Ordinary shares (US$0.0001 par value per share; 500,000,000 authorized as of June 30, 2025 and 2024; 37,430,968 and 30,280,768 issued and outstanding as of June 30, 2025 and 2024, respectively)*
Additional paid-in capital
Subscription receivables
Accumulated other comprehensive loss
Retained earnings
Shareholders’ equity
Total liabilities and shareholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support